Recruit

A Postdoctoral Fellow position is available in the Wang lab at Department of Developmental and Cell Biology, University of California, Irvine (https://devcell.bio.uci.edu/faculty/wenqi-wang/) to study the Hippo signaling pathway in organ size control and cancer development.

We are taking advantage of multi-disciplinary approaches including integrated proteomics/bioinformatics analyses, in-depth biochemical studies and sophisticated genetic mouse models to dissect regulation and function of the Hippo pathway in normal physiology and cancer development. Through it, we hope to develop therapeutic approaches by utilizing the Hippo pathway for cancer treatment. We also conduct large-scale proteomics studies exploring various cancer related signaling pathways and protein families with the emphasis on their cross-talk with the Hippo pathway.

We are seeking a highly motivated, independent, and career-oriented candidate with research expertise in molecular biology, biochemistry, cell biology and cancer biology. We prefer candidates who are about to graduate with PhD or MD/PhD degree, or have graduated within the last 12 months. A track record of excellent first author publication(s) is required. The salary and benefit will follow the NIH standard.

To apply, one should submit their curriculum vitae and the contact information via the following recruitment URL: https://recruit.ap.uci.edu/JPF08057

The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.

As a condition of employment, you will be required to comply with the University of California Policy on Vaccination Programs – With Updated Interim Amendments. All Covered Individuals under the policy must provide proof of receiving the COVID-19 Vaccine Primary Series or, if applicable, submit a request for Exception (based on Medical Exemption, Disability, Religious Objection, and/or Deferral based on pregnancy or recent COVID-19 diagnosis and/or treatment) no later than the applicable deadline. All Covered Individuals must also provide proof of receiving the most recent CDC-recommended COVID-19 booster or properly decline such booster no later than the applicable deadline. New University of California employees should refer to Exhibit 2, Section II.C. of the SARS-CoV-2 (COVID-19) Vaccination Program Attachment for applicable deadlines. All Covered Individuals must also provide proof of being up-to-date on seasonal influenza vaccination or properly decline such vaccination no later than the applicable deadline. Please refer to the Seasonal Influenza Vaccination Program Attachment. (Capitalized terms in this paragraph are defined in the policy.) Federal, state, or local public health directives may impose additional requirements.